Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Current Pharmaceutical Design
  4. Volume 30, Issue 8
  5. Article
Volume 30, Issue 8
  • ISSN: 1381-6128
  • E-ISSN: 1873-4286

Abstract

Cardiovascular Disease (CVD) is one of the most prevalent diseases in the world, comprising a variety of disorders such as hypertension, heart attacks, Peripheral Vascular Disease (PVD), dyslipidemias, strokes, coronary heart disease, and cardiomyopathies. The World Health Organization (WHO) predicts that 22.2 million people will die from CVD in 2030. Conventional treatments for CVDs are often quite expensive and also have several side effects. This potentiates the use of medicinal plants, which are still a viable alternative therapy for a number of diseases, including CVD. Natural products' cardio-protective effects result from their anti-oxidative, anti-hypercholesterolemia, anti-ischemic, and platelet aggregation-inhibiting properties. The conventional therapies used to treat CVD have the potential to be explored in light of the recent increase in the popularity of natural goods and alternative medicine. Some natural products with potential in the management of cardiovascular diseases such as L., , , L., , are discussed in this article.

© 2024 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cpd/10.2174/0113816128295053240207090928
2024-03-01
2024-11-06

  • From This Site

    /content/journals/cpd/10.2174/0113816128295053240207090928
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. BachhetiR.K. Prevention and treatment of cardiovascular diseases with plant phytochemicals: A review.Evid. Based Complement. Alternat. Med.20222022574119810.1155/2022/5741198
     [Google Scholar]
  2. Global status report on noncommunicable diseases 2014. World Health Organization2014
     [Google Scholar]
  3. DziemitkoS. Harasim-SymborE. ChabowskiA. How do phytocannabinoids affect cardiovascular health? An update on the most common cardiovascular diseases.Ther. Adv. Chronic Dis.20231410.1177/2040622322114323936636553
     [Google Scholar]
  4. ShaitoA. ThuanD.T.B. PhuH.T. Herbal medicine for cardiovascular diseases: Efficacy, mechanisms, and safety.Front. Pharmacol.20201142210.3389/fphar.2020.0042232317975
     [Google Scholar]
  5. YadavS. A review article on current pharmacological status of cardioprotective plant.Curr Res Pharmaceut Sci20232743
     [Google Scholar]
  6. HesariM. MohammadiP. KhademiF. Current advances in the use of nanophytomedicine therapies for human cardiovascular diseases.Int. J. Nanomed2021163293331510.2147/IJN.S29550834007178
     [Google Scholar]
  7. JainS. ButtarH.S. ChintameneniM. KaurG. Prevention of cardiovascular diseases with anti-inflammatory and anti-oxidant nutraceuticals and herbal products: An overview of pre-clinical and clinical studies.Recent Pat. Inflamm. Allergy Drug Discov.201812214515710.2174/1872213X1266618081514480330109827
     [Google Scholar]
  8. BressA.P. ColantonioL.D. CooperR.S. Potential cardiovascular disease events prevented with adoption of the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline.Circulation20191391243610.1161/CIRCULATIONAHA.118.03564030586736
     [Google Scholar]
  9. ChangX. Natural drugs as a treatment strategy for cardiovascular disease through the regulation of oxidative stress.Oxid. Med. Cell. Longev.20202020543040710.1155/2020/5430407
     [Google Scholar]
  10. NyakudyaT.T. TshabalalaT. DangarembiziR. ErlwangerK.H. NdhlalaA.R. The potential therapeutic value of medicinal plants in the management of metabolic disorders.Molecules20202511266910.3390/molecules2511266932526850
     [Google Scholar]
  11. ShangA. CaoS.Y. XuX.Y. Bioactive compounds and biological functions of garlic (Allium sativum L.).Foods20198724610.3390/foods807024631284512
     [Google Scholar]
  12. ImaizumiV.M. LaurindoL.F. ManzanB. Garlic: A systematic review of the effects on cardiovascular diseases.Crit. Rev. Food Sci. Nutr.202363246797681910.1080/10408398.2022.204382135193446
     [Google Scholar]
  13. AltafR. Sources and possible mechanisms of action of important phytoconstituents with cardiovascular properties.Afr. J. Pharm. Pharmacol.201269563580
     [Google Scholar]
  14. DaiberA. XiaN. StevenS. New therapeutic implications of endothelial nitric oxide synthase (eNOS) function/dysfunction in cardiovascular disease.Int. J. Mol. Sci.201920118710.3390/ijms2001018730621010
     [Google Scholar]
  15. MajewskiM. Allium sativum: Facts and myths regarding human health.Rocz. Panstw. Zakl. Hig.20146511824964572
     [Google Scholar]
  16. ShoukR. AbdouA. ShettyK. SarkarD. EidA.H. Mechanisms underlying the antihypertensive effects of garlic bioactives.Nutr. Res.201434210611510.1016/j.nutres.2013.12.00524461311
     [Google Scholar]
  17. EntezariM.H. AslaniN. AskariG. MaghsoudiZ. MaracyM. Effect of garlic and lemon juice mixture on lipid profile and some cardiovascular risk factors in people 30-60 years old with moderate hyperlipidaemia: A randomized clinical trial.Int. J. Prev. Med.2016719510.4103/2008‑7802.18724827563431
     [Google Scholar]
  18. LawsonL. HunsakerS. Allicin bioavailability and bioequivalence from garlic supplements and garlic foods.Nutrients201810781210.3390/nu1007081229937536
     [Google Scholar]
  19. YangY. LiY. WangJ. Systematic investigation of Ginkgo biloba leaves for treating cardio-cerebrovascular diseases in an animal model.ACS Chem. Biol.20171251363137210.1021/acschembio.6b0076228333443
     [Google Scholar]
  20. MesquitaT.R.R. de JesusI.C.G. dos SantosJ.F. Cardioprotective action of Ginkgo biloba extract against sustained β-adrenergic stimulation occurs via activation of M2/NO pathway.Front. Pharmacol.2017822010.3389/fphar.2017.0022028553225
     [Google Scholar]
  21. HongJ.M. ShinD.H. LimY.A. LeeJ.S. JooI.S. Ticlopidine with Ginkgo biloba extract: A feasible combination for patients with acute cerebral ischemia.Thromb. Res.20131314e147e15310.1016/j.thromres.2013.01.02623477707
     [Google Scholar]
  22. SilvaE.A.P. CarvalhoJ.S. GuimarãesA.G. The use of terpenes and derivatives as a new perspective for cardiovascular disease treatment: A patent review (2008-2018).Expert Opin. Ther. Pat.2019291435310.1080/13543776.2019.155821130583706
     [Google Scholar]
  23. SongC.E. An overview of cinchona alkaloids in chemistry.In: Cinchona Alkaloids in Synthesis and Catalysis: Ligands, Immobilization and Organocatalysis.Wiley200910.1002/9783527628179.ch1
     [Google Scholar]
  24. MazzantiA. TenutaE. MarinoM. Efficacy and limitations of quinidine in patients with Brugada syndrome.Circ. Arrhythm. Electrophysiol.2019125e00714310.1161/CIRCEP.118.007143
     [Google Scholar]
  25. AnwarM.A. Al DisiS.S. EidA.H. Anti-hypertensive herbs and their mechanisms of action: Part II.Front. Pharmacol.201675010.3389/fphar.2016.0005027014064
     [Google Scholar]
  26. KimJ.H. Cardiovascular diseases and Panax ginseng: A review on molecular mechanisms and medical applications.J. Ginseng Res.2012361162610.5142/jgr.2012.36.1.1623717100
     [Google Scholar]
  27. DengJ. WangY.W. ChenW.M. WuQ. HuangX.N. Role of nitric oxide in ginsenoside Rg(1)-induced protection against left ventricular hypertrophy produced by abdominal aorta coarctation in rats.Biol. Pharm. Bull.201033463163510.1248/bpb.33.63120410597
     [Google Scholar]
  28. ShahrajabianM.H. A review of three ancient Chinese herbs, goji berry, ginger and ginseng in pharmacological and modern science.J. Biol. Environm. Sci.20191339161171
     [Google Scholar]
  29. LeeC.H. KimJ.H. A review on the medicinal potentials of ginseng and ginsenosides on cardiovascular diseases.J. Ginseng Res.201438316116610.1016/j.jgr.2014.03.00125378989
     [Google Scholar]
  30. SarupP BalaS KambojS Pharmacology and phytochemistry of oleogum resin of Commiphora wightii (Guggulu).Scientifica20152015
     [Google Scholar]
  31. ChanderR. RizviF. KhannaA.K. PratapR. Cardioprotective activity of synthetic guggulsterone (E and Z-isomers) in isoproterenol induced myocardial ischemia in rats: A comparative study.Indian J. Clin. Biochem.2003182717910.1007/BF0286737023105395
     [Google Scholar]
  32. MotaA.H. A review of medicinal plants used in therapy of cardiovascular diseases.Int J Pharmacogn Phytochem Res20168572591
     [Google Scholar]
  33. Dal CeroM. SallerR. LeontiM. WeckerleC.S. Trends of medicinal plant use over the last 2000 years in central Europe.Plants202212113510.3390/plants1201013536616265
     [Google Scholar]
  34. ReddyB.A. Digitalis therapy in patients with congestive heart failure.Int. J. Pharm. Sci. Rev. Res.2010329095
     [Google Scholar]
  35. AbeysingheD. Nutritive importance and therapeutics uses of three different varieties (Murraya koenigii, Micromelum minutum, and Clausena indica) of curry leaves: An updated review.Evid-Based Complemen Altern Med20212021
     [Google Scholar]
  36. GopalR. AmbihaR. SivasubramanianN. Effect of curry leaves in lowering blood pressure among hypertensive Indian patients.Bioinformation202319101020102410.6026/97320630019102037969660
     [Google Scholar]
  37. WahabS. AnnaduraiS. AbullaisS.S. Glycyrrhiza glabra (Licorice): A comprehensive review on its phytochemistry, biological activities, clinical evidence and toxicology.Plants20211012275110.3390/plants1012275134961221
     [Google Scholar]
  38. MarkinaY.V. KirichenkoT.V. MarkinA.M. Atheroprotective effects of Glycyrrhiza glabra L.Molecules20222715469710.3390/molecules2715469735897875
     [Google Scholar]
  39. Pourbagher-ShahriA.M. FarkhondehT. AshrafizadehM. TalebiM. SamargahndianS. Curcumin and cardiovascular diseases: Focus on cellular targets and cascades.Biomed. Pharmacother.202113611121410.1016/j.biopha.2020.11121433450488
     [Google Scholar]
  40. KocaadamB. ŞanlierN. Curcumin, an active component of turmeric (Curcuma longa), and its effects on health.Crit. Rev. Food Sci. Nutr.201757132889289510.1080/10408398.2015.107719526528921
     [Google Scholar]
  41. KarimiA. Moini JazaniA. DarziM. Doost AzgomiR.N. VajdiM. Effects of curcumin on blood pressure: A systematic review and dose-response meta-analysis.Nutr. Metab. Cardiovasc. Dis.202333112089210110.1016/j.numecd.2023.07.00337567790
     [Google Scholar]
  42. DuJ. SunL.N. XingW.W. Lipid-lowering effects of polydatin from Polygonum cuspidatum in hyperlipidemic hamsters.Phytomedicine2009166-765265810.1016/j.phymed.2008.10.00119106037
     [Google Scholar]
  43. KeJ. LiM.T. XuS. MaJ. LiuM.Y. HanY. Advances for pharmacological activities of Polygonum cuspidatum - A review.Pharm. Biol.202361117718810.1080/13880209.2022.215834936620922
     [Google Scholar]
  44. FogacciF. TocciG. PrestaV. FratterA. BorghiC. CiceroA.F.G. Effect of resveratrol on blood pressure: A systematic review and meta-analysis of randomized, controlled, clinical trials.Crit. Rev. Food Sci. Nutr.201959101605161810.1080/10408398.2017.142248029359958
     [Google Scholar]
  45. dos Santos BaiãoD. Vieira Teixeira da SilvaD. Margaret Flosi PaschoalinV. A narrative review on dietary strategies to provide nitric oxide as a non-drug cardiovascular disease therapy: Beetroot formulations-A smart nutritional intervention.Foods202110485910.3390/foods1004085933920855
     [Google Scholar]
  46. ChauhanS. ChamoliK. SharmaS. Beetroot-A review paper.J. Pharmacogn. Phytochem.202092S424427
     [Google Scholar]
  47. SilvaD.V.T. BaiãoD.S. FerreiraV.F. PaschoalinV.M.F. Betanin as a multipath oxidative stress and inflammation modulator: A beetroot pigment with protective effects on cardiovascular disease pathogenesis.Crit. Rev. Food Sci. Nutr.202262253955410.1080/10408398.2020.182227732997545
     [Google Scholar]
  48. ColesL.T. CliftonP.M. Effect of beetroot juice on lowering blood pressure in free-living, disease-free adults: A randomized, placebo-controlled trial.Nutr. J.201211110610.1186/1475‑2891‑11‑10623231777
     [Google Scholar]
  49. BhallaA. Native medicines and cardiovascular toxicity.In: Heart and toxins.Elsevier201517520210.1016/B978‑0‑12‑416595‑3.00006‑2
     [Google Scholar]
  50. KatareC. SaxenaS. AgrawalS. Lipid-lowering and antioxidant functions of bottle gourd (Lagenaria siceraria) extract in human dyslipidemia.J. Evid. Based Complementary Altern. Med.201419211211810.1177/215658721452422924647091
     [Google Scholar]
  51. UpaganlawarA. BalaramanR. Cardioprotective effects of Lagenaria siceraria fruit juice on isoproterenol-induced myocardial infarction in wistar rats: A biochemical and histoarchitecture study.J. Young Pharm.20113429730310.4103/0975‑1483.9024122224036
     [Google Scholar]
  52. SyedQ.A. RashidZ. AhmadM.H. Nutritional and therapeutic properties of fenugreek (Trigonella foenum-graecum): A review.Int. J. Food Prop.20202311777179110.1080/10942912.2020.1825482
     [Google Scholar]
  53. JainP.G. A comprehensive review on plant derived natural products for diabetes and its complication as nephropathy.J. Drug Deliv. Ther.201992-s625633
     [Google Scholar]
  54. NikolaevaM. JohnstoneM. Nitric oxide, its role in diabetes mellitus and methods to improve endothelial function.In: Diabetes and Cardiovascular Disease.Springer202310.1007/978‑3‑031‑13177‑6_7
     [Google Scholar]
  55. VisuvanathanT. ThanL.T.L. StanslasJ. ChewS.Y. VellasamyS. Revisiting Trigonella foenum-graecum L.: Pharmacology and therapeutic potentialities.Plants20221111145010.3390/plants1111145035684222
     [Google Scholar]
  56. Heshmat-GhahdarijaniK. MashayekhiaslN. AmerizadehA. Teimouri JervekaniZ. SadeghiM. Effect of fenugreek consumption on serum lipid profile: A systematic review and meta‐analysis.Phytother. Res.20203492230224510.1002/ptr.669032385866
     [Google Scholar]
  57. AskarpourM. AlamiF. CampbellM.S. VenkatakrishnanK. HadiA. GhaediE. Effect of fenugreek supplementation on blood lipids and body weight: A systematic review and meta-analysis of randomized controlled trials.J. Ethnopharmacol.202025311253810.1016/j.jep.2019.11253832087319
     [Google Scholar]
  58. IritiM. VitaliniS. FicoG. FaoroF. Neuroprotective herbs and foods from different traditional medicines and diets.Molecules20101553517355510.3390/molecules1505351720657497
     [Google Scholar]
  59. Stompor-GorącyM. The health benefits of emodin, a natural anthraquinone derived from rhubarb-A summary update.Int. J. Mol. Sci.20212217952210.3390/ijms2217952234502424
     [Google Scholar]
  60. CatalfamoL.M. MarroneG. BasilicataM. The utility of Capsicum annuum L. in internal medicine and in dentistry: A comprehensive review.Int. J. Environ. Res. Public Health202219181118710.3390/ijerph19181118736141454
     [Google Scholar]
  61. EghbaliS. Therapeutic effects of Punica granatum (pomegranate): An updated review of clinical trials.J Nutrit Metabol2021
     [Google Scholar]
  62. SinghJ. KaurH.P. VermaA. Pomegranate peel phytochemistry, pharmacological properties, methods of extraction, and its application: A comprehensive review.ACS Omega2023839354523546910.1021/acsomega.3c0258637810640
     [Google Scholar]
  63. Rababa’hA.M. AlzoubiM.A. Origanum majorana L. extract protects against isoproterenol-induced cardiotoxicity in rats.Cardiovasc. Toxicol.202121754355210.1007/s12012‑021‑09645‑233786740
     [Google Scholar]
  64. KarakolP. KapiE. Use of selected antioxidant-rich spices and herbs in foods.In: Antioxidants-Benefits, Sources, Mechanisms of Action.intechopen202110.5772/intechopen.96136
     [Google Scholar]
  65. WangX. YangS. LiY. JinX. LuJ. WuM. Role of emodin in atherosclerosis and other cardiovascular diseases: Pharmacological effects, mechanisms, and potential therapeutic target as a phytochemical.Biomed. Pharmacother.202316111453910.1016/j.biopha.2023.11453936933375
     [Google Scholar]
  66. DwivediS. ChopraD. Revisiting Terminalia arjuna-An ancient cardiovascular drug.J. Tradit. Complement. Med.20144422423110.4103/2225‑4110.13910325379463
     [Google Scholar]
  67. KumarV. SharmaN. OrfaliR. Multitarget potential of phytochemicals from traditional medicinal tree, Terminalia arjuna (roxb. ex dc.) wight & arnot as potential medicaments for cardiovascular disease: An in-silico approach.Molecules2023283104610.3390/molecules2803104636770716
     [Google Scholar]
  68. DaiN. ZhaoF. FangM. PuF. KongL. LiuJ. Gynostemma pentaphyllum for dyslipidemia: A systematic review of randomized controlled trials.Front. Pharmacol.20221391752110.3389/fphar.2022.91752136091752
     [Google Scholar]
  69. RazaviB-M. HosseinzadehH. Cardiovascular effects of saffron and its active constituents.In: Saffron.Elsevier202045146010.1016/B978‑0‑12‑818638‑1.00030‑7
     [Google Scholar]
  70. KamalipourM. AkhondzadehS. Cardiovascular effects of saffron: An evidence-based review.J. Tehran Univ. Heart Cent.201162596123074606
     [Google Scholar]
  71. AnaeigoudariF. AnaeigoudariA. Kheirkhah-VakilabadA. A review of therapeutic impacts of saffron (Crocus sativus L.) and its constituents.Physiol. Rep.20231115e1578510.14814/phy2.1578537537722
     [Google Scholar]
  72. EllisL.R. ZulfiqarS. HolmesM. MarshallL. DyeL. BoeschC. A systematic review and meta-analysis of the effects of Hibiscus sabdariffa on blood pressure and cardiometabolic markers.Nutr. Rev.20228061723173710.1093/nutrit/nuab10434927694
     [Google Scholar]
  73. SapianS. Ibrahim MzeA.A. JubaidiF.F. Therapeutic potential of Hibiscus sabdariffa Linn. in attenuating cardiovascular risk factors.Pharmaceuticals202316680710.3390/ph1606080737375755
     [Google Scholar]
  74. TiwariM. BarooahM.S. A comprehensive review on the ethno-medicinal and pharmacological properties of Terminalia chebula fruit.Phytochem. Rev.202312110.1007/s11101‑023‑09878‑9
     [Google Scholar]
  75. SultanM.T. AnwarM.J. ImranM. Phytochemical profile and pro-healthy properties of Terminalia chebula: A comprehensive review.Int. J. Food Prop.202326152655110.1080/10942912.2023.2166951
     [Google Scholar]
/content/journals/cpd/10.2174/0113816128295053240207090928
Loading
The Potential of Natural Products in the Management of Cardiovascular Disease
Curr. Pharm. Des. 30, 624 (2024); https://doi.org/10.2174/0113816128295053240207090928
/content/journals/cpd/10.2174/0113816128295053240207090928
/content/journals/cpd/10.2174/0113816128295053240207090928
Loading

Data & Media loading...

  • Article Type: Review Article
Keyword(s): anti-hypercholesterolemia agents; anti-ischemic agents; anti-oxidative agents; Cardiovascular diseases; natural products; platelet aggregation

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test